Ambev S.A. $ABEV Stock Bought by Robeco Institutional Asset Management B.V.

Robeco Institutional Asset Management B.V. increased its stake in shares of Ambev S.A. (NYSE:ABEV) by 483.9% in the 3rd quarter, HoldingsChannel reports. The institutional investor owned 340,465 shares of the company’s stock after acquiring an additional 282,152 shares during the quarter. Robeco Institutional Asset Management B.V.’s holdings in Ambev were worth $994,000 as of its most recent SEC filing.

Several other institutional investors have also bought and sold shares of ABEV. First Eagle Investment Management LLC raised its position in Ambev by 0.7% in the 2nd quarter. First Eagle Investment Management LLC now owns 349,323,217 shares of the company’s stock valued at $1,096,875,000 after buying an additional 2,338,660 shares during the last quarter. Renaissance Technologies LLC grew its stake in shares of Ambev by 6.5% in the 1st quarter. Renaissance Technologies LLC now owns 27,354,300 shares of the company’s stock worth $79,875,000 after acquiring an additional 1,674,900 shares in the last quarter. Formuepleje A S bought a new stake in shares of Ambev in the 3rd quarter worth $23,610,000. DJE Kapital AG bought a new stake in shares of Ambev in the 1st quarter worth $14,778,000. Finally, Pzena Investment Management LLC grew its stake in shares of Ambev by 6.7% in the 1st quarter. Pzena Investment Management LLC now owns 4,717,328 shares of the company’s stock worth $13,775,000 after acquiring an additional 295,709 shares in the last quarter. Institutional investors own 8.13% of the company’s stock.

Insider Buying and Selling at Ambev

In other news, insider Carla Smith De Vasconcellos Crippa Prado sold 60,757 shares of Ambev stock in a transaction on Thursday, September 3rd. The stock was sold at an average price of $3.09, for a total transaction of $187,739.13. Following the sale, the insider directly owned 80,707 shares in the company, valued at $249,384.63. The trade was a 42.95% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Manuel Moreira sold 468,040 shares of Ambev stock in a transaction on Thursday, July 30th. The stock was sold at an average price of $3.08, for a total value of $1,441,563.20. Following the sale, the director owned 3,000,000 shares in the company, valued at $9,240,000. The trade was a 13.50% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing.

Ambev Stock Performance

Shares of ABEV opened at $2.83 on Tuesday. The stock has a 50 day moving average of $3.03 and a 200 day moving average of $3.02. The company has a market capitalization of $44.68 billion, a price-to-earnings ratio of 14.17, a PEG ratio of 2.08 and a beta of 0.58. Ambev S.A. has a 12 month low of $2.18 and a 12 month high of $3.45. The company has a current ratio of 1.02, a quick ratio of 0.76 and a debt-to-equity ratio of 0.02.

Ambev (NYSE:ABEV) last posted its quarterly earnings data on Wednesday, July 29th. The company reported $0.04 earnings per share for the quarter, hitting the consensus estimate of $0.04. Ambev had a return on equity of 17.48% and a net margin of 18.47%. The business had revenue of $3.89 billion for the quarter, compared to analysts’ expectations of $4.05 billion. As a group, sell-side analysts forecast that Ambev S.A. will post 0.21 earnings per share for the current year.

Ambev Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, January 11th. Stockholders of record on Wednesday, September 23rd will be given a dividend of $0.0092 per share. The ex-dividend date of this dividend is Wednesday, September 23rd. This represents a $0.04 annualized dividend and a dividend yield of 1.3%. Ambev’s dividend payout ratio (DPR) is currently 15.00%.

Wall Street Analyst Weigh In

Several brokerages have recently commented on ABEV. UBS Group set a $2.85 target price on shares of Ambev in a report on Tuesday, August 11th. Weiss Ratings upgraded shares of Ambev from a “hold (c+)” rating to a “buy (b-)” rating in a report on Thursday, October 8th. Wall Street Zen raised shares of Ambev from a “hold” rating to a “buy” rating in a research report on Saturday, October 10th. Bank of America reaffirmed an “underperform” rating and issued a $3.30 price objective on shares of Ambev in a research report on Wednesday, October 7th. Finally, Scotiabank lowered shares of Ambev from a “sector outperform” rating to a “sector perform” rating in a research note on Wednesday, July 15th. One analyst has rated the stock with a Buy rating, three have issued a Hold rating and two have given a Sell rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Reduce” and an average target price of $3.13.

Ambev Profile

Ambev SA is a Brazilian beverage company headquartered in São Paulo and one of the largest beverage producers in Latin America. Its principal business is the production, distribution and sale of beer, although it also offers soft drinks, carbonated beverages, bottled water, energy drinks and other non-alcoholic products.

The company’s beer portfolio includes brands such as Brahma, Skol, Antarctica, Bohemia, Original, Budweiser, Stella Artois and Corona, with brand availability varying by market.